Samsung Biologics reports provisional interim results of PolyPeptide tender offer

Samsung Biologics, via Samsung Peptide, released a provisional interim result for its public tender offer for PolyPeptide registered shares. The offer targets all publicly held PolyPeptide shares listed on SIX under PPGN. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PolyPeptide Group AG published the original content used to generate this news brief on October 13, 2026, and is solely responsible for the information contained therein. (C)